-
1
-
-
67949106233
-
Diagnostic accuracy and impact of computed tomographic coronary angiography on utilization of invasive coronary angiography
-
Chow BJ, Abraham A, Wells GA, Chen L, Ruddy TD, Yam Y, Govas N, Galbraith PD, Dennie C, Beanlands RS. Diagnostic accuracy and impact of computed tomographic coronary angiography on utilization of invasive coronary angiography. Circ Cardiovasc Imaging. 2009;2:16-23. doi: 10.1161/CIRCIMAGING.108.792572.
-
(2009)
Circ Cardiovasc Imaging.
, vol.2
, pp. 16-23
-
-
Chow, B.J.1
Abraham, A.2
Wells, G.A.3
Chen, L.4
Ruddy, T.D.5
Yam, Y.6
Govas, N.7
Galbraith, P.D.8
Dennie, C.9
Beanlands, R.S.10
-
2
-
-
77349086611
-
Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction
-
Chow BJ, Wells GA, Chen L, Yam Y, Galiwango P, Abraham A, Sheth T, Dennie C, Beanlands RS, Ruddy TD. Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction. J Am Coll Cardiol. 2010;55:1017-1028. doi: 10.1016/j.jacc.2009.10.039.
-
(2010)
J Am Coll Cardiol.
, vol.55
, pp. 1017-1028
-
-
Chow, B.J.1
Wells, G.A.2
Chen, L.3
Yam, Y.4
Galiwango, P.5
Abraham, A.6
Sheth, T.7
Dennie, C.8
Beanlands, R.S.9
Ruddy, T.D.10
-
3
-
-
79959302822
-
Ontario multidetector computed tomographic coronary angiography study: Field evaluation of diagnostic accuracy
-
Chow BJ, Freeman MR, Bowen JM, et al. Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med. 2011;171:1021-1029. doi: 10.1001/ archinternmed.2011.74.
-
(2011)
Arch Intern Med.
, vol.171
, pp. 1021-1029
-
-
Chow, B.J.1
Freeman, M.R.2
Bowen, J.M.3
-
4
-
-
21344460533
-
Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: A comparative study with quantitative coronary angiography and intravascular ultrasound
-
Leber AW, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S, Wintersperger B, Reiser M, Becker CR, Steinbeck G, Boekstegers P. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: A comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol. 2005;46:147-154. doi: 10.1016/j.jacc.2005.03.071.
-
(2005)
J Am Coll Cardiol.
, vol.46
, pp. 147-154
-
-
Leber, A.W.1
Knez, A.2
Von Ziegler, F.3
Becker, A.4
Nikolaou, K.5
Paul, S.6
Wintersperger, B.7
Reiser, M.8
Becker, C.R.9
Steinbeck, G.10
Boekstegers, P.11
-
5
-
-
77957049654
-
Lesion characteristics and coronary stent selection with computed tomographic coronary angiography: A pilot investigation comparing CTA, QCA and IVUS
-
Kass M, Glover CA, Labinaz M, So DY, Chen L, Yam Y, Chow BJ. Lesion characteristics and coronary stent selection with computed tomographic coronary angiography: A pilot investigation comparing CTA, QCA and IVUS. J Invasive Cardiol. 2010;22:328-334.
-
(2010)
J Invasive Cardiol.
, vol.22
, pp. 328-334
-
-
Kass, M.1
Glover, C.A.2
Labinaz, M.3
So, D.Y.4
Chen, L.5
Yam, Y.6
Chow, B.J.7
-
6
-
-
79952353616
-
Diagnostic performance of non-invasive multidetector computed tomography coronary angiography to detect coronary artery disease using different endpoints: Detection of significant stenosis vs
-
van Velzen JE, Schuijf JD, de Graaf FR, Boersma E, Pundziute G, Spanó F, Boogers MJ, Schalij MJ, Kroft LJ, de Roos A, Jukema JW, van der Wall EE, Bax JJ. Diagnostic performance of non-invasive multidetector computed tomography coronary angiography to detect coronary artery disease using different endpoints: detection of significant stenosis vs. detection of atherosclerosis. Eur Heart J. 2011;32:637-645. doi: 10.1093/eurheartj/ ehq395.
-
(2011)
Detection of Atherosclerosis. Eur Heart J.
, vol.32
, pp. 637-645
-
-
Van Velzen, J.E.1
Schuijf, J.D.2
De Graaf, F.R.3
Boersma, E.4
Pundziute, G.5
Spanó, F.6
Boogers, M.J.7
Schalij, M.J.8
Kroft, L.J.9
De Roos, A.10
Jukema, J.W.11
Van Der Wall, E.E.12
Bax, J.J.13
-
7
-
-
33845392672
-
Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: Comparison to IVUS
-
Pohle K, Achenbach S, Macneill B, Ropers D, Ferencik M, Moselewski F, Hoffmann U, Brady TJ, Jang IK, Daniel WG. Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis. 2007;190:174-180. doi: 10.1016/j. atherosclerosis.2006.01.013.
-
(2007)
Atherosclerosis.
, vol.190
, pp. 174-180
-
-
Pohle, K.1
Achenbach, S.2
Macneill, B.3
Ropers, D.4
Ferencik, M.5
Moselewski, F.6
Hoffmann, U.7
Brady, T.J.8
Jang, I.K.9
Daniel, W.G.10
-
9
-
-
70350360003
-
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations
-
Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol. 2009;25:567-579.
-
(2009)
Can J Cardiol.
, vol.25
, pp. 567-579
-
-
Genest, J.1
McPherson, R.2
Frohlich, J.3
-
10
-
-
84874812584
-
Statins for the primary prevention of cardiovascular disease
-
Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011;CD004816.
-
(2011)
Cochrane Database Syst Rev
, pp. CD004816
-
-
Taylor, F.1
Ward, K.2
Moore, T.H.3
Burke, M.4
Davey Smith, G.5
Ward, K.6
Ebrahim, S.7
-
11
-
-
77954179995
-
Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants
-
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N. Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170:1024-1031. doi: 10.1001/archinternmed.2010.182.
-
(2010)
Arch Intern Med.
, vol.170
, pp. 1024-1031
-
-
Ray, K.K.1
Seshasai, S.R.2
Erqou, S.3
Sever, P.4
Jukema, J.W.5
Ford, I.6
Sattar, N.7
-
12
-
-
65849268320
-
Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
-
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373:1849-1860.
-
(2009)
Lancet
, vol.373
, pp. 1849-1860
-
-
Baigent, C.1
Blackwell, L.2
Collins, R.3
Emberson, J.4
Godwin, J.5
Peto, R.6
Buring, J.7
Hennekens, C.8
Kearney, P.9
Meade, T.10
Patrono, C.11
Roncaglioni, M.C.12
Zanchetti, A.13
-
13
-
-
53049084464
-
Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography
-
Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, Flores F, Mao SS, Budoff MJ. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2008;52:1335-1343. doi: 10.1016/j.jacc.2008.07.027.
-
(2008)
J Am Coll Cardiol.
, vol.52
, pp. 1335-1343
-
-
Ostrom, M.P.1
Gopal, A.2
Ahmadi, N.3
Nasir, K.4
Yang, E.5
Kakadiaris, I.6
Flores, F.7
Mao, S.S.8
Budoff, M.J.9
-
14
-
-
82755165684
-
Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events
-
Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, Jørgensen E, Kelbæk H, Prescott E. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33:734-744. doi: 10.1093/eurheartj/ehr331.
-
(2012)
Eur Heart J.
, vol.33
, pp. 734-744
-
-
Jespersen, L.1
Hvelplund, A.2
Abildstrøm, S.Z.3
Pedersen, F.4
Galatius, S.5
Madsen, J.K.6
Jørgensen, E.7
Kelbæk, H.8
Prescott, E.9
-
15
-
-
0015966216
-
Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve
-
Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87-94.
-
(1974)
Am J Cardiol.
, vol.33
, pp. 87-94
-
-
Gould, K.L.1
Lipscomb, K.2
Hamilton, G.W.3
-
16
-
-
0027987849
-
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
17
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
-
(1998)
JAMA.
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
Whitney, E.4
Shapiro, D.R.5
Beere, P.A.6
Langendorfer, A.7
Stein, E.A.8
Kruyer, W.9
Gotto, A.M.10
-
18
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
-
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307. doi: 10.1056/NEJM199511163332001.
-
(1995)
N Engl J Med.
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
Macfarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
19
-
-
0037164314
-
PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
-
Shepherd J, Blauw GJ, Murphy MB, et al.; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet. 2002;360:1623-1630.
-
(2002)
Lancet.
, vol.360
, pp. 1623-1630
-
-
PROSPER study group1
Shepherd, J.2
Blauw, G.J.3
Murphy, M.B.4
-
20
-
-
33746431474
-
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)
-
Knopp RH, d'Emden M, Smilde JG, Pocock SJ. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care. 2006;29:1478-1485. doi: 10.2337/dc05-2415.
-
(2006)
Diabetes Care.
, vol.29
, pp. 1478-1485
-
-
Knopp, R.H.1
D'emden, M.2
Smilde, J.G.3
Pocock, S.J.4
-
21
-
-
8144224441
-
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
-
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004;110:2809-2816. doi: 10.1161/01.CIR.0000146378.65439.7A.
-
(2004)
Circulation.
, vol.110
, pp. 2809-2816
-
-
Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators1
Asselbergs, F.W.2
Diercks, G.F.3
Hillege, H.L.4
Van Boven, A.J.5
Janssen, W.M.6
Voors, A.A.7
De Zeeuw, D.8
De Jong, P.E.9
Van Veldhuisen, D.J.10
Van Gilst, W.H.11
-
22
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
23
-
-
84859480711
-
Evidence-based use of statins for primary prevention of cardiovascular disease
-
Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med. 2012;125:440-446. doi: 10.1016/j.amjmed.2011.11.013.
-
(2012)
Am J Med.
, vol.125
, pp. 440-446
-
-
Minder, C.M.1
Blaha, M.J.2
Horne, A.3
Michos, E.D.4
Kaul, S.5
Blumenthal, R.S.6
-
24
-
-
84863393148
-
Meta-analysis of statin effects in women versus men
-
Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59:572-582. doi: 10.1016/j.jacc.2011.09.067.
-
(2012)
J Am Coll Cardiol.
, vol.59
, pp. 572-582
-
-
Kostis, W.J.1
Cheng, J.Q.2
Dobrzynski, J.M.3
Cabrera, J.4
Kostis, J.B.5
-
25
-
-
79958001356
-
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary
-
Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol. 2011;27:208-221. doi: 10.1016/j. cjca.2010.12.033.
-
(2011)
Can J Cardiol.
, vol.27
, pp. 208-221
-
-
Bell, A.D.1
Roussin, A.2
Cartier, R.3
-
26
-
-
33644556119
-
Visualizing coronary calcium is associated with improvements in adherence to statin therapy
-
Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394-399. doi: 10.1016/j. atherosclerosis.2005.06.018.
-
(2006)
Atherosclerosis.
, vol.185
, pp. 394-399
-
-
Kalia, N.K.1
Miller, L.G.2
Nasir, K.3
Blumenthal, R.S.4
Agrawal, N.5
Budoff, M.J.6
-
27
-
-
41049105993
-
Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors
-
Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, Blumenthal RS, Budoff MJ. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008;101:999-1002. doi: 10.1016/j. amjcard.2007.11.059.
-
(2008)
Am J Cardiol.
, vol.101
, pp. 999-1002
-
-
Orakzai, R.H.1
Nasir, K.2
Orakzai, S.H.3
Kalia, N.4
Gopal, A.5
Musunuru, K.6
Blumenthal, R.S.7
Budoff, M.J.8
-
28
-
-
0030331092
-
Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors?
-
Wong ND, Detrano RC, Diamond G, Rezayat C, Mahmoudi R, Chong EC, Tang W, Puentes G, Kang X, Abrahamson D. Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol. 1996;78:1220-1223.
-
(1996)
Am J Cardiol.
, vol.78
, pp. 1220-1223
-
-
Wong, N.D.1
Detrano, R.C.2
Diamond, G.3
Rezayat, C.4
Mahmoudi, R.5
Chong, E.C.6
Tang, W.7
Puentes, G.8
Kang, X.9
Abrahamson, D.10
-
29
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 1998; 339:1349-1357.
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
30
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207. doi: 10.1056/ NEJMoa0807646.
-
(2008)
N Engl J Med.
, vol.359
, pp. 2195-2207
-
-
JUPITER Study Group1
Ridker, P.M.2
Danielson, E.3
Fonseca, F.A.4
Genest, J.5
Gotto, A.M.6
Kastelein, J.J.7
Koenig, W.8
Libby, P.9
Lorenzatti, A.J.10
Macfadyen, J.G.11
Nordestgaard, B.G.12
Shepherd, J.13
Willerson, J.T.14
Glynn, R.J.15
-
31
-
-
0001667150
-
The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998-3007.
-
(2002)
JAMA
, vol.288
, pp. 2998-3007
-
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group1
-
32
-
-
0037420492
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
-
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 2003;361:1149-1158. doi: 10.1016/ S0140-6736(03)12948-0.
-
(2003)
Lancet.
, vol.361
, pp. 1149-1158
-
-
ASCOT investigators1
Sever, P.S.2
Dahlöf, B.3
Poulter, N.R.4
Wedel, H.5
Beevers, G.6
Caulfield, M.7
Collins, R.8
Kjeldsen, S.E.9
Kristinsson, A.10
McInnes, G.T.11
Mehlsen, J.12
Nieminen, M.13
O'brien, E.14
Ostergren, J.15
-
33
-
-
66849104414
-
Absence of coronary artery calcification and all-cause mortality
-
Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, Callister T, Raggi P, Blumenthal RS, Nasir K. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging. 2009;2:692-700. doi: 10.1016/j.jcmg.2009.03.009.
-
(2009)
JACC Cardiovasc Imaging.
, vol.2
, pp. 692-700
-
-
Blaha, M.1
Budoff, M.J.2
Shaw, L.J.3
Khosa, F.4
Rumberger, J.A.5
Berman, D.6
Callister, T.7
Raggi, P.8
Blumenthal, R.S.9
Nasir, K.10
|